Regeneron Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 350.78

REGN Stock  USD 966.30  2.75  0.29%   
Regeneron Pharmaceuticals' implied volatility is one of the determining factors in the pricing options written on Regeneron Pharmaceuticals. Implied volatility approximates the future value of Regeneron Pharmaceuticals based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Regeneron Pharmaceuticals over a specific time period. For example, 2024-03-28 CALL at $967.5 is a CALL option contract on Regeneron Pharmaceuticals' common stock with a strick price of 967.5 expiring on 2024-03-28. The contract was last traded on 2024-03-27 at 15:59:40 for $3.8 and, as of today, has 0 days remaining before the expiration. The option is currently trading at a bid price of $3.5, and an ask price of $4.3. The implied volatility as of the 28th of March is 21.5. View All Regeneron options

Closest to current price Regeneron long CALL Option Payoff at Expiration

Regeneron Pharmaceuticals' future price is the expected price of Regeneron Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Regeneron Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Regeneron Pharmaceuticals Backtesting, Regeneron Pharmaceuticals Valuation, Regeneron Pharmaceuticals Correlation, Regeneron Pharmaceuticals Hype Analysis, Regeneron Pharmaceuticals Volatility, Regeneron Pharmaceuticals History as well as Regeneron Pharmaceuticals Performance.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.
  
At this time, Regeneron Pharmaceuticals' Price Fair Value is very stable compared to the past year. Please specify Regeneron Pharmaceuticals' target price for which you would like Regeneron Pharmaceuticals odds to be computed.

Regeneron Pharmaceuticals Target Price Odds to finish over 350.78

The tendency of Regeneron Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 350.78  in 90 days
 966.30 90 days 350.78 
close to 99
Based on a normal probability distribution, the odds of Regeneron Pharmaceuticals to stay above $ 350.78  in 90 days from now is close to 99 (This Regeneron Pharmaceuticals probability density function shows the probability of Regeneron Stock to fall within a particular range of prices over 90 days) . Probability of Regeneron Pharmaceuticals price to stay between $ 350.78  and its current price of $966.3 at the end of the 90-day period is about 75.95 .
Given the investment horizon of 90 days Regeneron Pharmaceuticals has a beta of 0.58 indicating as returns on the market go up, Regeneron Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Regeneron Pharmaceuticals will be expected to be much smaller as well. Additionally Regeneron Pharmaceuticals has an alpha of 0.1319, implying that it can generate a 0.13 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Regeneron Pharmaceuticals Price Density   
       Price  

Predictive Modules for Regeneron Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Regeneron Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Regeneron Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
869.67967.49968.45
Details
Intrinsic
Valuation
LowRealHigh
869.67984.26985.22
Details
Naive
Forecast
LowNextHigh
962.28963.24964.20
Details
28 Analysts
Consensus
LowTargetHigh
830.39912.521,013
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Regeneron Pharmaceuticals. Your research has to be compared to or analyzed against Regeneron Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Regeneron Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Regeneron Pharmaceuticals.

Regeneron Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Regeneron Pharmaceuticals is not an exception. The market had few large corrections towards the Regeneron Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Regeneron Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Regeneron Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
0.13
β
Beta against NYSE Composite0.58
σ
Overall volatility
33.47
Ir
Information ratio 0.08

Regeneron Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Regeneron Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Regeneron Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Regeneron Pharmaceuticals is unlikely to experience financial distress in the next 2 years
Over 89.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Global Metastatic Melanoma Therapeutics Market Anticipates Robust Growth with New Therapeutic Developments

Regeneron Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Regeneron Stock often depends not only on the future outlook of the current and potential Regeneron Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regeneron Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding113.7 M
Cash And Short Term Investments10.8 B

Regeneron Pharmaceuticals Technical Analysis

Regeneron Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Regeneron Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Regeneron Pharmaceuticals. In general, you should focus on analyzing Regeneron Stock price patterns and their correlations with different microeconomic environments and drivers.

Regeneron Pharmaceuticals Predictive Forecast Models

Regeneron Pharmaceuticals' time-series forecasting models is one of many Regeneron Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Regeneron Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Regeneron Pharmaceuticals

Checking the ongoing alerts about Regeneron Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Regeneron Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Regeneron Pharmaceuticals is unlikely to experience financial distress in the next 2 years
Over 89.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Global Metastatic Melanoma Therapeutics Market Anticipates Robust Growth with New Therapeutic Developments
When determining whether Regeneron Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regeneron Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regeneron Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regeneron Pharmaceuticals Stock:
Check out Regeneron Pharmaceuticals Backtesting, Regeneron Pharmaceuticals Valuation, Regeneron Pharmaceuticals Correlation, Regeneron Pharmaceuticals Hype Analysis, Regeneron Pharmaceuticals Volatility, Regeneron Pharmaceuticals History as well as Regeneron Pharmaceuticals Performance.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.
Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Regeneron Stock analysis

When running Regeneron Pharmaceuticals' price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Stocks Directory
Find actively traded stocks across global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.03)
Earnings Share
34.78
Revenue Per Share
122.935
Quarterly Revenue Growth
0.006
Return On Assets
0.0849
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.